Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.
María Muñoz-San MartínGemma ReverterRene R Robles-CedeñoMaria BuxóFrancisco José OrtegaImma GómezJordi Tomàs-RoigNaiara CelarainLuisa Maria VillarHector PerkalJosé Manuel Fernandez RealEster QuintanaLluis Ramio-TorrentàPublished in: Journal of neuroinflammation (2019)
Levels of miR-21 and miR-146a/b in cell-free CSF may represent valuable biomarkers to identify patients with active MS lesions.